Related Experiment Video
Updated: Jan 9, 2026

Author Spotlight: Exploring Seaweed's Bioactive Compounds for Sustainable Innovations in Industries
Published on: November 21, 2023
Content, bio-accessibility and intake of iodine from seaweed-containing food products available in The Netherlands
Alida Melse-Boonstra1, Rinke Bossink2, Vera Sollie2
1Division of Human Nutrition and Health, Wageningen University & Research, Stippeneng 4, 6708 WE, Wageningen, The Netherlands. alida.melse@wur.nl.
Purpose:
Consumption of seaweed products has become increasingly popular in certain consumer segments, but the high iodine content of some of these products is of concern. We aimed to 1) assess the amount of iodine present in a selection of seaweed products; 2) determine iodine bio-accessibility from these products; and 3) estimate the daily intake of iodine from seaweed-containing products by Dutch consumers.
Methods:
Seaweed products were purchased and analysed for iodine content by ICP-MS. Bio-accessibility (solubility) of iodine was determined by a static in vitro digestion model (INFOGEST), which mimics human digestive processes. Data on dietary intake of iodine from seaweed and other food products were collected from 80 regular consumers of seaweed products with an online food frequency questionnaire over the last month.
Results:
Iodine content of the seaweed products ranged from < 0.1 to 7910 µg/g of fresh weight (3.5 to 36,975 µg/serving). Bio-accessibility of iodine ranged from 24 to 56%, and was higher in products that were processed to a higher degree. Median daily iodine intake of the respondents was 270 µg/day (range: 68-16,544 µg/day), with 25% of seaweed consumers exceeding the upper limit (UL) for iodine intake of 600 µg/day over the last month.
Conclusion:
Iodine content was very high in several of the seaweed products, which was also reflected by the high proportion of seaweed consumers who structurally exceeded the UL. In vitro data suggest relatively low bioavailability of iodine from seaweed products, but this remains to be confirmed by in vivo studies.
Related Concept Videos
Bioavailability: Overview
Bioavailability: Overview
Key Elements for Plant Nutrition
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Bioavailability: Influencing Factors
Non-Oral Extravascular Drug Absorption Routes
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...

